Thomas Soh
- Gastrointestinal (oesophageal, gastric, colon and rectal cancer)
- Hepatobiliary Cancer (liver, pancreas, bile duct, and gallbladder cancers)
Dr Thomas Soh is an accredited medical practitioner by the the Office of the Public guardian, to assist patients with making a Lasting Power of Attorney (LPA).
He was previously Consultant at the Department of Haematology Oncology at National University Hospital (NUH) and Visiting Consultant at Ng Teng Fong General Hospital.
He graduated from National University of Singapore in 2003 and received his Membership of the Royal College of Physician (United Kingdom) in 2007. He later completed his advance specialist training in Medical Oncology in 2012.
He was heavily involved in both undergraduate and postgraduate education, and was core faculty for the both the Internal Medicine Residency program and the Oncology Senior Residency program in the National University Hospital from 2012 to 2016. He was recognised for his mentorship and a good teacher to junior doctors and medical students, with the Teaching Excellence Award in 2014, from National University Cancer Institute (NCIS), as well as the Best Tutor Award in 2015 for undergraduate teaching by the University Medical Cluster, NUH.
Dr Soh believes in the delivery of quality healthcare, and was the lead and co-lead in several healthcare improvement projects. He had received multiple awards for his involvement in the Clinical Practice Improvement Programmes that he had implemented in NUH. From 2013-2015, he contributed a leading role being the Honorary Secretary of the Executive Committee, Singapore Society of Oncology.
Graduated from the National University of Singapore in 2003
Obtained Membership of the Royal College of Physician (United Kingdom) in 2007
Awarded Teaching Excellence Award in 2014, NCIS
Awarded NUH UMC Undergraduate Teaching Best Tutor Award in 2015
Research funding from the National Medical Research Council (NMRC), Singapore, being awarded the Clinical Investigator Salary Support Program (CISSP) award 3 times
Research work was published in more than 10 publications relating to hepatocellular carcinoma, colorectal cancer, pancreatic cancer and other gastrointestinal cancers.
Subspecialty oncology interest in gastrointestinal (oesophageal, stomach, colon and rectal cancers) and hepatobiliary cancers (liver, pancreas, bile duct, and gallbladder cancers).
Membership of the Royal College of Physician (United Kingdom) in 2007
English
Opening Hours
Accepted Insurance
AIAAXAAllianzFullertonGreat EasternMHCNTUC IncomeParkway ShentonPrudential
Accepted Panel
GetDoc
Our Website
Our Story
Since its founding in 2007, OncoCare Cancer Centre in Singapore has been committed to providing the best available cancer care to our patients through expert, personalized treatments, driven by state of the art knowledge and making a difference through efficient delivery, effective communication, and compassionate touch. We seek to cure, to relieve and to partner our patients on their cancer journey by using our understanding of the detection, diagnosis, treatment, and prevention of cancer. We aim to reduce toxicity, control symptoms, prevent disfigurement, eliminate pain, and emotional distress associated with cancer-directed therapy.
We believe that today’s research leads to tomorrow’s cure and our doctors are actively involved in clinical research and trials, have a dynamic collaboration with regional cancer institutions and laboratories. We have access to the latest commercial imaging, molecular genetic laboratories associated with world-class science and technology.
Our core values are excellence, compassion and integrity.
Opening Hours
Accepted Insurance
AIAAXAAllianzFullertonGreat EasternMHCNTUC IncomeParkway ShentonPrudential
Accepted Panel
GetDoc
Our Website
Our Story
Since its founding in 2007, OncoCare Cancer Centre in Singapore has been committed to providing the best available cancer care to our patients through expert, personalized treatments, driven by state of the art knowledge and making a difference through efficient delivery, effective communication, and compassionate touch. We seek to cure, to relieve and to partner our patients on their cancer journey by using our understanding of the detection, diagnosis, treatment, and prevention of cancer. We aim to reduce toxicity, control symptoms, prevent disfigurement, eliminate pain, and emotional distress associated with cancer-directed therapy.
We believe that today’s research leads to tomorrow’s cure and our doctors are actively involved in clinical research and trials, have a dynamic collaboration with regional cancer institutions and laboratories. We have access to the latest commercial imaging, molecular genetic laboratories associated with world-class science and technology.
Our core values are excellence, compassion and integrity.
Opening Hours
Accepted Insurance
AIAAXAAllianzFullertonGreat EasternMHCNTUC IncomeParkway ShentonPrudential
Accepted Panel
GetDoc
Our Website
Our Story
Since its founding in 2007, OncoCare Cancer Centre in Singapore has been committed to providing the best available cancer care to our patients through expert, personalized treatments, driven by state of the art knowledge and making a difference through efficient delivery, effective communication, and compassionate touch. We seek to cure, to relieve and to partner our patients on their cancer journey by using our understanding of the detection, diagnosis, treatment, and prevention of cancer. We aim to reduce toxicity, control symptoms, prevent disfigurement, eliminate pain, and emotional distress associated with cancer-directed therapy.
We believe that today’s research leads to tomorrow’s cure and our doctors are actively involved in clinical research and trials, have a dynamic collaboration with regional cancer institutions and laboratories. We have access to the latest commercial imaging, molecular genetic laboratories associated with world-class science and technology.
Our core values are excellence, compassion and integrity.